[{"type": "title", "data": "Penicillin Allergy Testing - Inpatient (Multiphase) PROTOTYPE"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "For patients with medium to high risk of reaction", "value": ""}, {"type": "note", "data": "For Nurses with Advanced Skill: RN must receive specialized education and training and be competency checked by Clinical Nurse Educator to perform penicillin skin testing", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Vital Signs", "value": ""}, {"type": "sentence", "data": "once, PRIOR to Penicillin Skin Test"}, {"type": "order", "data": "Vital Signs", "value": ""}, {"type": "sentence", "data": "AFTER Penicillin Skin Test. Stay with patient for 10 minutes to observe for any signs or symptoms of anaphylaxis, and reassess after 30 minutes and 60 minutes"}, {"type": "order", "data": "Skin Assessment", "value": ""}, {"type": "sentence", "data": "once, PRIOR to Penicillin Skin Test"}, {"type": "order", "data": "Skin Assessment", "value": ""}, {"type": "sentence", "data": "AFTER Penicillin Skin Test. Stay with patient for 10 minutes to observe for any signs or symptoms of anaphylaxis, and reassess after 30 minutes and 60 minutes"}, {"type": "category", "data": "Medications"}, {"type": "order", "data": "histamine 0.1 mg/1 mL inj", "value": "checked"}, {"type": "sentence", "data": "0.003 mg, intradermal, once, drug form: inj"}, {"type": "order", "data": "benzylpenicilloyl-polylysine 0.25 mL", "value": "checked"}, {"type": "sentence", "data": "0.03 mL, intradermal, once, drug form: inj"}, {"type": "order", "data": "minor determinant mixture inj", "value": "checked"}, {"type": "sentence", "data": "0.03 mL, intradermal, once, drug form: inj"}, {"type": "note", "data": "Adverse Reaction Management", "value": ""}, {"type": "note", "data": "Select or modify the medications within Hypersensitivity / Anaphylaxis Module as required", "value": ""}, {"type": "sub phase", "data": "Hypersensitivity / Anaphylaxis Treatment (Module)", "value": ""}, {"type": "category", "data": "Procedures"}, {"type": "note", "data": "Skin Test Components - For skin prick and intradermal testing as per protocol", "value": ""}, {"type": "order", "data": "Penicillin Skin Test", "value": "checked"}, {"type": "sentence", "data": "Routine, Reason: Penicillin Skin Test"}, {"type": "category", "data": "Admit/Transfer/Discharge"}, {"type": "note", "data": "For patients with low risk of reaction and/ or a NEGATIVE intradermal test", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Skin Assessment", "value": ""}, {"type": "sentence", "data": "once, PRIOR to Penicillin Oral Challenge"}, {"type": "order", "data": "Skin Assessment", "value": ""}, {"type": "sentence", "data": "AFTER Penicillin Oral Challenge. Stay with patient for 10 minutes to observe for any signs or symptoms of anaphylaxis, and reassess after 30 minutes and 60 minutes"}, {"type": "order", "data": "Vital Signs", "value": ""}, {"type": "sentence", "data": "once, PRIOR to Penicillin Oral Challenge"}, {"type": "order", "data": "Vital Signs", "value": ""}, {"type": "sentence", "data": "AFTER Penicillin Oral Challenge. Stay with patient for 10 minutes to observe for any signs or symptoms of anaphylaxis, and reassess after 30 minutes and 60 minutes"}, {"type": "category", "data": "Medications"}, {"type": "order", "data": "amoxicillin", "value": ""}, {"type": "sentence", "data": "250 mg, PO, as directed, drug form: cap, start: T;N+120"}, {"type": "order", "data": "ampicillin", "value": ""}, {"type": "sentence", "data": "1,000 mg, IV, as directed, start: T;N+120"}, {"type": "note", "data": "Adverse Reaction Management", "value": ""}, {"type": "note", "data": "Select or modify the medications within Hypersensitivity / Anaphylaxis Module as required", "value": ""}, {"type": "sub phase", "data": "Hypersensitivity / Anaphylaxis Treatment (Module)", "value": ""}]
